SCHEMBL2405684

SCHEMBL2405684

CC(C)CCB(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10732337 0.81
SCHEMBL13197061 0.79 ARG2 (0.46)
SCHEMBL15496504 0.78
SCHEMBL21344517 0.74 KDM4E (0.32)
SCHEMBL3180989 0.72 LMNA (0.35)
SCHEMBL12503947 0.71
SCHEMBL12503949 0.71
SCHEMBL8708538 0.71
SCHEMBL12503953 0.69
SCHEMBL7178186 0.69 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170226395-A1 THERMAL ENERGY STORAGE PHASE CHANGE MATERIALS COMPRISING BORONIC ACIDS AND METHODS OF MAKING AND USING THEM ENTROPY SOLUTIONS LLC (US) 2017-08-10 US claimed
WO-2016025536-A1 THERMAL ENERGY STORAGE PHASE CHANGE MATERIALS COMPRISING BORONIC ACIDS AND METHODS OF MAKING AND USING THEM ENTROPY SOLUTIONS INC. (US) 2016-02-18 WO claimed
US-20100236924-A1 LIQUID ELECTROLYTE COMPOSITION AND ITS USE IN GAS SENSORS LIFE SAFETY DISTRIBUTION AG (CH) 2010-09-23 US claimed
EP-2226627-A1 Liquid electrolyte composition and its use in gas sensors Life Safety Distribution AG (CH) 2010-09-08 EP claimed
EP-4665458-A1 INHIBITING ALPHA V BETA8 INTEGRIN Morphic Therapeutic, Inc. (US) 2025-12-24 EP disclosed
WO-2024173572-A1 INHIBITING α vβ8 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2024-08-22 WO disclosed
US-12054502-B2 Multifunctional immunity-targeted micromolecule anti-cancer medicine Bestazomib (Bestazomib) and preparation method and application thereof SHANDONG HUBBLE KISEN BIOLOGICAL TECHNONLOGY CO., LTD. (CN) 2024-08-06 US disclosed
EP-3377473-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2024-06-19 EP disclosed
US-20240166618-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2024-05-23 US disclosed
CN-117945995-A Alkylated nitrogen-containing heterocyclic compound and preparation method and application thereof 中国科学院青海盐湖研究所 2024-04-30 CN disclosed
CN-117642379-A Phenylalkylamines and methods of making and using the same 吉尔伽美什制药公司 2024-03-01 CN disclosed
EP-4305019-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME Gilgamesh Pharmaceuticals, Inc. (US) 2024-01-17 EP disclosed
US-20100087646-A1 REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-04-08 US disclosed
WO-2009067453-A1 COMBINATIONS OF HDAC INHIBITORS AND PROTEASOME INHIBITORS SYNDAX PHARMACEUTICALS, INC. (US) 2009-05-28 WO disclosed
US-5763203-A Immobilization and separation of cells and other particles SINVENT AS (NO) 1998-06-09 US disclosed
EP-0688430-B1 IMMOBILISATION AND SEPARATION OF CELLS AND OTHER PARTICLES SINVENT AS (NO) 1997-05-28 EP disclosed
US-4634722-A CONTACT LENSES FROM PROTECTED ACRYLIC ESTER DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1987-01-06 US disclosed
US-4409335-A Method for eliminating glucose dependent Schiff base effect from hemoglobin A1 assay BIO-RAD LABORATORIES, INC. (US) 1983-10-11 US disclosed
US-4401797-A ADDUCT OF DIHYDROXYPROPYL (METH)ACRYLATE AND BORONIC ACID SYNTEX (U.S.A.) INC. (US) 1983-08-30 US disclosed
US-4269605-A COMPLEXING WITH A DIHYDROXYBORYL BONDED TO A SUPPORT; QUANTITATIVE ANALYSIS OF GLYCOSYLATED HEMOGLOBIN; DIABETES AMICON CORPORATION (US) 1981-05-26 US disclosed